WARRANT TO PURCHASE SHARES OF COMMON STOCKSecurity Agreement • October 16th, 2024 • 180 Life Sciences Corp. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, [__], or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October 17, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from 180 Life Sciences, Inc., a Delaware corporation (the “Company”), up to [__] shares of Common Stock, par value $0.0001 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Re: 180 Life Sciences Corp. – Financial Advisory AgreementFinancial Advisory Agreement • October 16th, 2024 • 180 Life Sciences Corp. • Pharmaceutical preparations • New York
The purpose of this letter (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by 180 Life Sciences Corp., a Delaware corporation (the “Company”), to render Financial Services (as defined below) to the Company.
